Zymedyne aims to develop safer, more effective treatments for chronic, neuropathic pain by targeting human Cav3.2 “T-type” calcium channels that are known to be crucial in pain signalling. Unlike opioids, our technology aims to achieve pain relief without the detrimental side effects of weight gain,... Read more
This company has no offices yet
Transcure
2 followers
Emi Health
1 follower
Thriveworks
3 followers
Nucleus
1 follower
TORTUS
1 follower
Amplified Sciences
2 followers
Philips
318 followers
Apollo Global Management
68 followers
Nestlé Health Science
58 followers
LianMedical
1 follower
Xeltis
3 followers
Johns Hopkins Aramco Healthcare (JHAH)
13 followers